LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.17783
 11.56 771.67 1299 1280 1.0143 1.0394
MN20160304_L01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 11.56 771.67 1134 1280 0.8855 0.6934
MN20160304_L01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 13.78 771.67 1446 1459 0.9906 0.9795
MN20160304_L01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 13.78 771.67 1217 1459 0.8337 0.6411
MN20160304_L01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 16.00 771.67 1497 1585 0.9442 0.8924
MN20160304_L01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 16.00 771.67 1274 1585 0.8035 0.6203
MN20160304_L01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 18.22 771.67 1558 1741 0.8947 0.8192
MN20160304_L01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 18.22 771.67 1346 1741 0.7730 0.6061
MN20160304_L01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 20.44 771.67 1617 1910 0.8462 0.7603
MN20160304_L01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 20.44 771.67 1413 1910 0.7395 0.5879
MN20160304_L01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 22.66 771.67 1651 2141 0.7710 0.6762
MN20160304_L01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 22.66 771.67 1486 2141 0.6939 0.5605
MN20160304_L01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 24.89 771.67 1779 2397 0.7420 0.6664
MN20160304_L01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 24.89 771.67 1574 2397 0.6565 0.5462
MN20160304_L01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 27.11 771.67 1901 2675 0.7106 0.6531
MN20160304_L01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 27.11 771.67 1671 2675 0.6246 0.5385
MN20160304_L01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 29.33 771.67 2012 2939 0.6845 0.6433
MN20160304_L01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 29.33 771.67 1782 2939 0.6063 0.5431
MN20160304_L01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 31.55 771.67 2161 3196 0.6760 0.6523
MN20160304_L01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 31.55 771.67 1895 3196 0.5928 0.5498
MN20160304_L01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 33.78 771.67 2312 3499 0.6606 0.6538
MN20160304_L01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 33.78 771.67 2043 3499 0.5838 0.5626
MN20160304_L01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 36.00 771.67 2450 3884 0.6307 0.6413
MN20160304_L01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 36.00 771.67 2172 3884 0.5591 0.5586
MN20160304_L01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 38.22 771.67 2612 4299 0.6075 0.6356
MN20160304_L01
E22